Levonorgestrel Stada (Levonorgestrel)

Levonorgestrel binds to progesterone receptors in the hypothalamus and pituitary, suppressing the luteinizing hormone surge that triggers ovulation. It also thickens cervical mucus, making it difficult for sperm to reach an egg, and induces endometrial changes that reduce the chance of implantation.

The specific dose and regimen of Levonorgestrel Stada are determined by the prescribing healthcare professional based on the indication, patient weight, timing of administration, and local regulatory guidance. Patients should follow the prescriber’s instructions and not alter the dose on their own.

Levonorgestrel Stada is intended for use in non‑pregnant individuals; it should not be started if pregnancy is already present. While limited data suggest minimal transfer into breast milk, the decision to use it while breastfeeding should be made by a healthcare provider weighing potential benefits against any theoretical risks to the infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements if applicable) and assists with import documentation.

Levonorgestrel Stada is a progestin‑only option, offering a smaller tablet size and no estrogen component, which can be advantageous for women who cannot tolerate estrogen. Compared with combined oral contraceptives, it has a slightly different side‑effect profile and may be less effective if taken later than the recommended window for emergency use.

Levonorgestrel Stada should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging to protect it from moisture and light. Do not store in bathrooms or near heat sources, and keep out of reach of children.

Levonorgestrel Stada is taken orally with a glass of water. For emergency contraception, it is usually taken as a single dose as soon as possible after unprotected intercourse, ideally within 72 hours. For regular contraception, the tablet is taken once daily at the same time each day, as directed by the prescriber.

Serious, though rare, risks include thromboembolic events such as deep‑vein thrombosis or pulmonary embolism, severe allergic reactions (anaphylaxis), and liver dysfunction. Patients should seek immediate medical attention if they experience unexplained chest pain, severe abdominal pain, swelling of the legs, or signs of an allergic reaction.

Levonorgestrel Stada is contraindicated in individuals who are pregnant, have a known hypersensitivity to levonorgestrel or any excipients, have active thromboembolic disease, hormone‑sensitive cancers (e.g., breast cancer), severe liver disease, or are smokers over 35 years old. A thorough medical assessment is required before initiating therapy.